AIV Logo AIV Assistant

Loading...

 Logo Orchid Pharma Limited - ORCHPHARMA.NS 746.50 INR

P/E
35.58
EPS
19.66
P/B
2.80
ROE
8.18
Beta
1.80
Target Price
1000.67 INR

746.500 INR

746.500 INR

Daily: +0.89%
Key Metrics

P/E: 35.58

EPS: 19.66

Book Value: 250.11

Price to Book: 2.80

Debt/Equity: 13.78

% Insiders: 69.837%

Growth

Revenue Growth: 0.09%

Earnings Growth: -0.37%

Estimates

Forward P/E: 20.90

Target Mean Price: 1000.67

 Logo About Orchid Pharma Limited - (ORCHPHARMA.NS)

Country: India

Sector: Health Care

Website: http://www.orchidpharma.com

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is based in Narsinghpur, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

Exchange Ticker
NSI (India) ORCHPHARMA.NS
Historical Dividends
Year Total Dividends
2012 3.00 INR
2011 3.00 INR
2010 10.00 INR
2009 1.00 INR
2008 3.00 INR
2007 3.00 INR
2006 3.00 INR
2005 2.67 INR
2004 2.67 INR
2003 2.67 INR
2002 2.67 INR

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion